More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$42.93B
EPS
4
P/E ratio
108.4
Price to sales
9.18
Dividend yield
--
Beta
1.149691
Previous close
$444.15
Today's open
$444.48
Day's range
$431.99 - $448.39
52 week range
$282.77 - $454.54
show more
CEO
Udit Batra
Employees
7900
Headquarters
Milford, MA
Exchange
New York Stock Exchange
Shares outstanding
98248111
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables Leverages Waters' unique ability to take an AI-directed experiment from the research bench into development and into Empower™ Software, carrying its audit trail as the molecule moves into downstream, regulated settings Joins Anthropic's Model Hardware Standard (MHS) research program designed to enable AI agents to operate Waters instrument hardware directly and autonomously, cutting instrument integration from weeks to hours Brings Anthropic's Model Context Protocol (MCP) to waters_connect™ Software, enabling scientists to direct Waters instruments through proprietary agents linked to large language models (LLMs), as well as Claude Science MILFORD, Mass., Oct. 13, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context Protocol (MCP) to its informatics platform and has joined Anthropic's Model Hardware Standard (MHS) research program.
PRNewsWire • Oct 13, 2026

Here's Why You Should Retain WAT Stock in Your Portfolio for Now
Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.
Zacks Investment Research • Oct 8, 2026

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m.
PRNewsWire • Oct 1, 2026

Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum
Waters NYSE: WAT President and Chief Executive Officer Udit Batra said the company's second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses.
MarketBeat • Sep 26, 2026

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
Seeking Alpha • Sep 23, 2026

Waters: Positive Momentum Rides High Again
Waters has rebounded sharply, with shares rising from $300 to $425 on solid organic and acquired sales growth. Water's full-year earnings guidance has only been modestly raised to $14 and change per share, despite significant share price appreciation. Valuation has expanded to 28–29x earnings, making the stock less appealing despite credible margin expansion and growth plans.
Seeking Alpha • Sep 23, 2026

Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry
WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
Zacks Investment Research • Sep 18, 2026

Everlywell Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced a partnership with Waters Corporation to ensure patients have access to the most comprehensive at-home HPV cervical cancer screening tool available in the U.S. today, the Onclarity™ HPV Self-Collection Kit, tested with the BD Onclarity™ HPV Assay.1 The new diagnostic-led solution supports health plans as they expand access to cervical cancer screening and make it easier for eligible members to complete recom.
Business Wire • Sep 16, 2026

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
PRNewsWire • Sep 14, 2026

Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
PRNewsWire • Sep 11, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Waters Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.